Table 2 Summary of clinicopathological features of tissues of bladder cancer.
Pt No. | Sex | Age | Grade | Stage | Pt No. | Sex | Age | Grade | Stage |
---|---|---|---|---|---|---|---|---|---|
1 | M | 76 | H | T2N0M0 | 26 | M | 68 | L | T2bN0M0 |
2 | M | 66 | L | T1N0M0 | 27 | M | 59 | L | T2bN0M0 |
3 | F | 41 | L | T1N0M0 | 28 | M | 51 | H | T2N0M0 |
4 | M | 59 | H | T4N0M0 | 29 | M | 63 | H | T2bN0M0 |
5 | F | 80 | H | T2N0M0 | 30 | M | 70 | L | T2aN0M0 |
6 | F | 74 | H | T3aN0MO | 31 | F | 73 | H | T2aN0M0 |
7 | M | 75 | H | T2bN0M0 | 32 | M | 74 | H | T3N0M0 |
8 | M | 69 | L | T1NxM0 | 33 | M | 57 | H | T4aN0MO |
9 | M | 63 | H | T1NxM0 | 34 | M | 45 | L | TaN0M0 |
10 | M | 77 | H | T1N0M0 | 35 | F | 61 | H | T3aN0MO |
11 | M | 59 | L | T1N0M0 | 36 | M | 52 | L | T1N0M0 |
12 | M | 64 | H | T3aN0MO | 37 | M | 65 | H | T2bN0M0 |
13 | M | 53 | L | T1N0M0 | 38 | M | 58 | H | T4aNOMO |
14 | M | 48 | L | TaN0M0 | 39 | M | 62 | H | T4aN0M0 |
15 | F | 56 | L | T1N0M0 | 40 | M | 66 | H | T2bN2M0 |
16 | F | 62 | L | T1N0M0 | 41 | F | 89 | H | T2bN0M0 |
17 | M | 60 | L | T2N0M0 | 42 | F | 72 | H | T3N0M0 |
18 | M | 57 | H | T2N0M0 | 43 | M | 65 | L | T1N0M0 |
19 | M | 71 | H | T2N0M0 | 44 | M | 74 | H | T2bN0M0 |
20 | F | 75 | H | T1N0M0 | 45 | M | 68 | H | T3N0M0 |
21 | M | 58 | H | T4aN3MO | 46 | F | 64 | H | T1N0M0 |
22 | F | 47 | H | T2N0M0 | 47 | M | 54 | H | T1N0M0 |
23 | M | 84 | L | T3N0M0 | 48 | M | 68 | L | TaN0M0 |
24 | M | 53 | L | T1N0M0 | 49 | M | 78 | H | T2aN0M0 |
25 | M | 63 | H | T3aN0MO |